DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES
A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide. La présente invention concerne une forme galénique à noyau dilatable comprenant une dispersion de 6-(cyclopropan...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SATHER, CRAIG ALLEN KESTUR, UMESH KOEHLER-KING, DORY BADAWY, SHERIF IBRAHIM FARAG KYBURZ, KYLE |
| description | A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.
La présente invention concerne une forme galénique à noyau dilatable comprenant une dispersion de 6-(cyclopropanamido)-4-((2-méthoxy-3-(1-méthyl-1H-1,2,4-triazol-3-yl)phényl)amino)-N-(méthyl-d3)pyridazine-3-carboxamide amorphe. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3192982A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3192982A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3192982A13</originalsourceid><addsrcrecordid>eNrjZLB28Q92dHdVcPMP8g0GkQohkd5GCp5-Hp5OniH-QcEKzv6-AUGewZ5-7grB4a4-Po5OPq5AwSDXYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu_saGxoaWRpYeRoaEyEEgCQmijk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES</title><source>esp@cenet</source><creator>SATHER, CRAIG ALLEN ; KESTUR, UMESH ; KOEHLER-KING, DORY ; BADAWY, SHERIF IBRAHIM FARAG ; KYBURZ, KYLE</creator><creatorcontrib>SATHER, CRAIG ALLEN ; KESTUR, UMESH ; KOEHLER-KING, DORY ; BADAWY, SHERIF IBRAHIM FARAG ; KYBURZ, KYLE</creatorcontrib><description>A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.
La présente invention concerne une forme galénique à noyau dilatable comprenant une dispersion de 6-(cyclopropanamido)-4-((2-méthoxy-3-(1-méthyl-1H-1,2,4-triazol-3-yl)phényl)amino)-N-(méthyl-d3)pyridazine-3-carboxamide amorphe.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220324&DB=EPODOC&CC=CA&NR=3192982A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220324&DB=EPODOC&CC=CA&NR=3192982A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SATHER, CRAIG ALLEN</creatorcontrib><creatorcontrib>KESTUR, UMESH</creatorcontrib><creatorcontrib>KOEHLER-KING, DORY</creatorcontrib><creatorcontrib>BADAWY, SHERIF IBRAHIM FARAG</creatorcontrib><creatorcontrib>KYBURZ, KYLE</creatorcontrib><title>DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES</title><description>A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.
La présente invention concerne une forme galénique à noyau dilatable comprenant une dispersion de 6-(cyclopropanamido)-4-((2-méthoxy-3-(1-méthyl-1H-1,2,4-triazol-3-yl)phényl)amino)-N-(méthyl-d3)pyridazine-3-carboxamide amorphe.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB28Q92dHdVcPMP8g0GkQohkd5GCp5-Hp5OniH-QcEKzv6-AUGewZ5-7grB4a4-Po5OPq5AwSDXYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu_saGxoaWRpYeRoaEyEEgCQmijk</recordid><startdate>20220324</startdate><enddate>20220324</enddate><creator>SATHER, CRAIG ALLEN</creator><creator>KESTUR, UMESH</creator><creator>KOEHLER-KING, DORY</creator><creator>BADAWY, SHERIF IBRAHIM FARAG</creator><creator>KYBURZ, KYLE</creator><scope>EVB</scope></search><sort><creationdate>20220324</creationdate><title>DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES</title><author>SATHER, CRAIG ALLEN ; KESTUR, UMESH ; KOEHLER-KING, DORY ; BADAWY, SHERIF IBRAHIM FARAG ; KYBURZ, KYLE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3192982A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SATHER, CRAIG ALLEN</creatorcontrib><creatorcontrib>KESTUR, UMESH</creatorcontrib><creatorcontrib>KOEHLER-KING, DORY</creatorcontrib><creatorcontrib>BADAWY, SHERIF IBRAHIM FARAG</creatorcontrib><creatorcontrib>KYBURZ, KYLE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SATHER, CRAIG ALLEN</au><au>KESTUR, UMESH</au><au>KOEHLER-KING, DORY</au><au>BADAWY, SHERIF IBRAHIM FARAG</au><au>KYBURZ, KYLE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES</title><date>2022-03-24</date><risdate>2022</risdate><abstract>A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.
La présente invention concerne une forme galénique à noyau dilatable comprenant une dispersion de 6-(cyclopropanamido)-4-((2-méthoxy-3-(1-méthyl-1H-1,2,4-triazol-3-yl)phényl)amino)-N-(méthyl-d3)pyridazine-3-carboxamide amorphe.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3192982A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T16%3A07%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SATHER,%20CRAIG%20ALLEN&rft.date=2022-03-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3192982A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |